# C-Further

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/c-further
Canonical HTML page: https://getbiobrief.com/entity/c-further

## Recent coverage (1 stories)

### Coya and MiNK Set for Key Earnings: Focus on Treg and iNKT Pipeline Milestones
2026-03-15 06:55:58 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Coya Therapeutics and MiNK Therapeutics are scheduled to report quarterly financial results this Tuesday, with investors focused on cash runway and clinical progress. These updates come at a critical juncture for both companies as they advance novel cell therapies for neurodegeneration and oncology, respectively.
Full story: https://getbiobrief.com/story/coya-mink-earnings-preview-cell-therapy-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.